Part 1: Obesity the Pandemic without End

Presented by Peter Katzmarzyk, PhD, FTOS

Learning Objectives:

• After participating in this session, attendees should be able to:
  • Describe the time trends and current global distribution in pediatric obesity.
  • Describe the U.S. and global temporal and geographic trends in adult obesity.

Part 2: Genetic Basis of Obesity

Presented by Claude Bouchard, PhD

Learning Objectives:

• Understand the contribution of genetic differences to the risk of human obesity based on observational and experimental studies
• Recognize the complex genomic architecture of human obesity
• Appreciate that the risk of most common forms of obesity is defined by the frequency and effect size of multiple obesity-promoting and thinness-promoting alleles

Part 3: Dietary Supplements for Weight Loss – Fact behind the Fiction

Presented by Steven Heymsfield, MD

Learning Objectives:

• Describe the key features and regulatory pathway for dietary supplements for weight loss.
• Identify the ingredients and their effectiveness that comprise dietary supplements.

Part 4: Weight loss and metabolic rate and adaptation

Presented by Eric Ravussin, PhD

Learning Objectives:

• Results from the Biggest Loser will be presented and discussed.
• The potential mechanisms underlying the metabolic adaptation will be presented
• We will discuss the role of metabolic adaptation in weight loss and weight loss maintenance

George Bray Keynote.

Learning Objectives: 

• Appreciate the variability of weight loss associated with all treatment approaches.
• Recognize that genetic differences significantly influence response to diets and that patients may need more than one diet before they find the best one.
• Understand that a variety of metabolic, behavioral, and dietary factors influence weight loss, independent of diet.

Please note: this lecture is not available for MOC credit.

Medications and Obesity Part 1

Presented by Donna Ryan, MD

Learning Objectives:

• At the end of the presentation, learners will be able to:
  • Discuss medications which increase body weight and alter body composition;
  • Recognize the mechanism of action of obesity medication;
  • Describe guideline-based recommendations for prescribing medications for obesity; and
  • Relate considerations and patient communications prior to initiating medication prescription.

Medications and Obesity Part 2

Presented by Donna Ryan, MD

Learning Objectives:

• At the end of the presentation, learners will be able to:
  • Discuss the safety and efficacy profiles of currently available medications approved for chronic weight management;
  • Describe the potential complications of rapid weight loss and how to avoid them;
  • Discuss medications that are used off-label for weight management; and
  • Review medications likely to be approved in the next 5 years for chronic weight management.

• Attendees will be able evaluate diets commonly used in behavioral interventions and determine the ones most appropriate for a given patient.
• Attendees will understand and recognize the value of using a nutrition professional to assess the patient’s current lifestyle and educate the individual on the diets providing specific information that would enable the patient to succeed in their weight loss efforts. 

• Understand the nuances of the History relevant to the evaluation of patients with overweight and obesity.
• Understand the aspects of Physical Exam relevant to the evaluation of patients with overweight and obesity.

• Focus on behavior modification, disease condition and management, preoperative cardiac risk assessment, and psychosocial optimization.

• Describe the main body components and how they are measured.
• Describe strengths and limitations of these methods when applied in the clinical setting.

Learning Objectives:

• Identify good candidates for an intensive behavioral intervention in your practice.

Presented by Katie Queen, MD

Please note: this lecture is not available for MOC credit.

Presented by Frank Greenway, MD